NCT02420626

Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Volcano Crux Vena Cava Filter Registry

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Volcano Corporation · Industry
• Sex: All
• Age: 19 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The Crux Vena Cava Filter (VCF) Registry is a clinical study, sponsored by Volcano Corporation, to evaluate the short and long term performance and clinical outcomes of the Crux Vena Cava Filter System.

Detailed description

The Crux VCF Registry is a non-randomized clinical study, sponsored by Volcano Corporation, to evaluate the short and long term performance and clinical outcomes of the Crux VCF System. The registry includes consecutive patients treated with the Crux VCF in a post-market (commercial) setting with data collection at the implant procedure through 2 years post implant or to filter retrieval, whichever comes first. Patients may also be enrolled (roll-in) from a previous Crux VCF implant within the previous 6 months. Follow up assessment will be performed at 6, 12 and 24 months post-implant and at the time of retrieval, if performed.

Conditions

• Pulmonary Embolism
• Venous Thromboembolism
• Deep Vein Thrombosis

Timeline

• Start date: 2016-01-01
• Primary completion: 2017-05-01
• Completion: 2019-05-01
• First posted: 2015-04-20
• Last updated: 2016-04-22

Locations

3 sites across 1 country: United States